Investigating ITIH2 expression in human breast cancer we were able to confirm the data obtained by CPA analysis (70% downregulation) by semiquantitative real-time RT-PCR (64% downregulation) in an additional set of breast tumors. The gene discussed is ITIH2; the disease is breast neoplasm.